Sign up to get updates from us
CEO
Hannah Went has a lifelong passion for longevity and breakthrough, disruptive technologies that drive radical improvement to the human condition. She attended the University of Kentucky and graduated with a degree in Biology. During that time, she had multiple research internships studying cell signaling and cell biology. After graduation, she worked for the International Peptide Society as their Director of Research and Content. Through work in the integrative medicine industry, Hannah saw an opportunity for methylation based age diagnostics and started TruDiagnostics in 2020. TruDiagnostic is a company focusing on methylation array-based diagnostics for life extension and preventive healthcare serving functional medicine providers. TruDiagnostic has a commitment to research with over 30 approved clinical trials investigating the epigenetic methylation changes of longevity and health interventions. Since TruDiagnostic’s inception, they have created one of the largest private epigenetic health databases in the world with over 75,000 patients tested to date. Hannah has since created Everything Epigenetics where she shares insights on how DNA regulation has an impact on your health.
Hannah Went attended the University of Kentucky and graduated with a degree in Biology. After graduation, she then worked for the International Peptide Society as their Director of Research and Content. Through work in the integrative medicine industry, Hannah saw an opportunity for methylation based age diagnostics and started TruDiagnostic in 2020. Hannah has since created Everything Epigenetics where she shares insights on how DNA regulation has an impact on your health.
I’ve had a lifelong passion for longevity and breakthrough, disruptive technologies that drive radical improvement to the human condition. In 2020, I saw an opportunity for methylation based age diagnostics and started TruDiagnostic. TruDiagnostic is a company focusing on methylation array-based diagnostics for life extension and preventive healthcare serving functional medicine providers. We have a commitment to research with over 30 approved clinical trials investigating the epigenetic methylation changes of longevity and health interventions. Since TruDiagnostic’s inception, we’ve created one of the largest private epigenetic health databases in the world with over 75,000 patients tested to date. I have since created Everything Epigenetics where I share research-backed insights on how DNA regulation has an impact on your health. With the background context above, my research interest centers around epigenetic DNA methylation as a biomarker to replace many of the traditional laboratory testing being used today and how we can use this testing to predict all cause-mortality and morbidity.